Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Introduction: Pharmacotherapy plays an important role in the treatment of major depression. At the initiation of antidepressant treatment, both improvement of symptoms in the short term and relapse prevention in the long term should be taken into account. However, there is insufficient evidence regarding the efficacy and the acceptability of continuation/maintenance treatments and the relative efficacy/acceptability of antidepressants. Objective: We will conduct a pairwise meta-analysis and a network meta-analysis (NMA) to examine the relative efficacy, tolerability and acceptability of antidepressants in the long-term treatment of major depression. Methods and analysis: We will include double-blind randomised controlled trials comparing any of the following antidepressants, which we included in our previous NMA of the acute treatment for major depression, with placebo or with another active drug for long-term treatment of major depression: agomelatine, amitriptyline, bupropion, citalopram, clomipramine, desvenlafaxine, duloxetine, escitalopram, fluoxetine, fluvoxamine, levomilnacipran, milnacipran, mirtazapine, nefazodone, paroxetine, reboxetine, sertraline, trazodone, venlafaxine, vilazodone and vortioxetine. Our primary outcomes will be sustained response and all-cause dropouts. We will include four types of designs that are used to investigate long-term treatment. We will conduct two main analyses. First, we will conduct a pairwise meta-analysis comparing all antidepressants versus placebo to investigate whether continuing antidepressants after achieving a positive response in the acute-phase treatment is beneficial and/or safe. Second, we will conduct an NMA to examine the comparative efficacy and acceptability of the drugs. We will use a novel approach that will combine the results of acute-phase treatment NMA with long-term treatment studies to include all related designs in the NMA. We will ensure the validity of combining different designs and our new approach by checking the distribution of important effect modifiers and consistency of network. Ethics and dissemination: This study did not require ethical approval. We will disseminate our findings by publishing results in a peer-reviewed journal. PROSPERO registration number: CRD42018114561; Pre-results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120 · cited 1×
“MEthOds We used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P).(16)”
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,171
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541 · cited 5×
“We will include the 21 antidepressants, which showed greater efficacy than placebo in the acute treatment of major depression in our previous review.(5) In this last, all antidepressants currently marketed in the USA, Europe or Japan were included: agomelatine, bupropion, citalopram, desvenlafaxine, duloxetine, escita…”
InfluentialSelf-citationFerrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
The Epidemiology of Depression Across Cultures
Kessler, R. C., & Bromet, E. J. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114409 · Cited by 2,657
Graphical tools for network meta-analysis in STATA
Chaimani, A., Higgins, J. P. T., Mavridis, D., Spyridonos, P., & Salanti, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076654 · Cited by 2,473 · cited 1×
“For NMA 1, we will use comparison-adjusted funnel plots, after assuming that newer treatments are favoured.(41) We will also evaluate the influence of publication bias by performing subgroup analyses of published versus unpublished data.”
MethodComparison of two methods to detect publication bias in meta-analysis.
Peters, J. L. (2006) · JAMA · doi:10.1001/jama.295.6.676 · Cited by 2,278
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
Higgins, J. P. T., Jackson, D., Barrett, J. K., Lu, G., Ades, A. E., & White, I. R. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1044 · Cited by 2,098 · cited 1×
“by-treatment test to assess the global inconsistency in the network.(39) In case we identify important inconsistency, we”
BackgroundKennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Conceptual and technical challenges in network meta-analysis
Cipriani, A., Higgins, J. P. T., Geddes, J. R., & Salanti, G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00008 · Cited by 1,072 · cited 1×
“32 However, synthesising the results of the four different designs that we expect to find (figure 1) via standard NMA methods poses a problem regarding transitivity, which is the underpinning assumption of the NMA model.(33) According to this assumption, there are no important differences between studies in clinical a…”
BackgroundSelf-citationRelapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1×
“We will classify studies into several groups based on the length of treatment (from the initiation of acute treatment to the end of continuation treatment: >3 and ≤6 months, >6 and ≤12 months, >12 and ≤24 months, and >24 months) to assess, using subgroup analyses, whether the duration of treatment leads to any differe…”
MethodSelf-citationLithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920 · cited 1×
“We define long-term treatment as the duration of treatment of more than 12 weeks.(17) We conceptualise the phases of treatment for major depression as consisting of the acute-phase treatment lasting up to 3 months, and the subsequent continuation/maintenance phase.”
MethodSelf-citationMalhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Self-citationLong-term treatment of depression.
Kupfer, D. J. (1991) · PubMed · Cited by 475
Turner, R. M., Jackson, D., Wei, Y., Thompson, S. G., & Higgins, J. P. T. (2015) · Statistics in Medicine · doi:10.1002/sim.6381 · Cited by 410 · cited 2×
“We will then report the estimated value for the heterogeneity variance and compare it with the corresponding empirical distribution.(35) 36 Finally, we will report the I(2) statistic,(37) which corresponds to the percentage of the variability due to heterogeneity rather than a sampling error.”
MethodGetReal in network meta-analysis: a review of the methodology
Efthimiou, O., Debray, T. P. A., van Valkenhoef, G., Trelle, S., Panayidou, K., Moons, K. G. M., Reitsma, J. B., Shang, A., Salanti, G., & on behalf of GetReal Methods Review Group (2016) · Research Synthesis Methods · doi:10.1002/jrsm.1195 · Cited by 401 · cited 1×
“Consistency is a reflection of the transitivity of the NMA, and a breach in the transitivity assumption may lead to important inconsistencies in the network.(32) In NMA 1, we will evaluate the consistency by using two approaches: via the back-calculation method to assess local inconsistency,(38) and the design-”
MethodSelf-citationRhodes, K. M., Turner, R. M., & Higgins, J. P. T. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.08.012 · Cited by 395
[Long-term treatment of depression].
Keller, M. B. (1994) · PubMed · Cited by 362
Langzeitbehandlung der Depression
Keller, M. B. (1994) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-1002360 · Cited by 362
Riley, R. D., Jackson, D., Salanti, G., Burke, D. L., Price, M., Kirkham, J., & White, I. R. (2017) · BMJ · doi:10.1136/bmj.j3932 · Cited by 247
The global prevalence of postpartum psychosis: a systematic review
on behalf of the Maternal Morbidity Working Group, VanderKruik, R., Barreix, M., Chou, D., Allen, T., Say, L., & Cohen, L. S. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1427-7 · Cited by 238
Practical guide to the meta-analysis of rare events
Efthimiou, O. (2018) · Evidence Based Mental Health · doi:10.1136/eb-2018-102911 · Cited by 231 · cited 1×
“Should the event be rare for some of the outcomes (eg, zero events in one or both treatment arms for some studies), we will consider alternative methods for meta-analysis.(30)”
MethodSelf-citationSim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv076 · Cited by 218 · cited 1×
“Once remitted from the acute phase of antidepressant therapy, should one continue the antidepressant? If yes, in view of such long-term treatment, which antidepressants, if any, would be preferred at the time of the initiation of the acute-phase treatment? Although previous systematic reviews of long-term treatment of…”
BackgroundFurukawa, T. A., Salanti, G., Atkinson, L. Z., Leucht, S., Ruhe, H. G., Turner, E. H., Chaimani, A., Ogawa, Y., Takeshima, N., Hayasaka, Y., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010919 · Cited by 214
Self-citationKönig, J., Krahn, U., & Binder, H. (2013) · Statistics in Medicine · doi:10.1002/sim.6001 · Cited by 205
Šprah, L., Dernovšek, M. Z., Wahlbeck, K., & Haaramo, P. (2017) · BMC Psychiatry · doi:10.1186/s12888-016-1172-3 · Cited by 196
Hansen, R., Gaynes, B., Thieda, P., Gartlehner, G., Deveaugh-Geiss, A., Krebs, E., & Lohr, K. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.10.1121 · Cited by 172
Demystifying fixed and random effects meta-analysis
Nikolakopoulou, A., Mavridis, D., & Salanti, G. (2014) · Evidence Based Mental Health · doi:10.1136/eb-2014-101795 · Cited by 156
Ades, A. E. (2003) · Statistics in Medicine · doi:10.1002/sim.1566 · Cited by 128
Validity of the posttraumatic stress disorders (PTSD) checklist in pregnant women
Gelaye, B., Zheng, Y., Medina-Mora, M. E., Rondon, M. B., Sánchez, S. E., & Williams, M. A. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1304-4 · Cited by 114
Evaluating novel agent effects in multiple-treatments meta-regression
Salanti, G., Dias, S., Welton, N. J., Ades, A. E., Golfinopoulos, V., Kyrgiou, M., Mauri, D., & Ioannidis, J. P. A. (2010) · Statistics in Medicine · doi:10.1002/sim.4001 · Cited by 111
Chaimani, A., Salanti, G., Leucht, S., Geddes, J. R., & Cipriani, A. (2017) · Evidence Based Mental Health · doi:10.1136/eb-2017-102753 · Cited by 106
Self-citationMeta-analysis of relapse prevention antidepressant trials in depressive disorders
Glue, P., Donovan, M. R., Kolluri, S., & Emir, B. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048671003705441 · Cited by 100
Long-term treatment of depression
(1998) · CRC Press eBooks · doi:10.1201/b14699-6 · Cited by 90
Deshauer, D., Moher, D., Fergusson, D., Moher, E., Sampson, M., & Grimshaw, J. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071068 · Cited by 78
Should we search Chinese biomedical databases when performing systematic reviews?
Cohen, J. F., Korevaar, D. A., Wang, J., Spijker, R., & Bossuyt, P. M. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0017-3 · Cited by 76 · cited 2×
“Moreover, recent studies have shown that the trials indexed in Chinese databases generally suffer from numerous quality issues,(24) and evaluating their credibility and integrity is beyond the scope of this work.(25) We therefore decided to exclude such studies to avoid any potential bias that might arise by their inc…”
BackgroundTong, Z., Li, F., Ogawa, Y., Watanabe, N., & Furukawa, T. A. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0554-2 · Cited by 61
Self-citationEfthimiou, O., Mavridis, D., Cipriani, A., Leucht, S., Bagos, P., & Salanti, G. (2014) · Statistics in Medicine · doi:10.1002/sim.6117 · Cited by 60
Self-citationHutton, B., Wolfe, D., Moher, D., & Shamseer, L. (2017) · Evidence Based Mental Health · doi:10.1136/eb-2017-102666 · Cited by 53
Joint synthesis of multiple correlated outcomes in networks of interventions
Efthimiou, O., Mavridis, D., Riley, R. D., Cipriani, A., & Salanti, G. (2015) · Biostatistics · doi:10.1093/biostatistics/kxu030 · Cited by 50
Self-citationEffectiveness of antidepressants
McCormack, J., & Korownyk, C. (2018) · BMJ · doi:10.1136/bmj.k1073 · Cited by 43
Long-Term Treatment of Depression with Antidepressants: A Systematic Narrative Review
Furukawa, T. A., Cipriani, A., Barbui, C., & Geddes, J. R. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200902 · Cited by 33
Self-citationSecond-generation antidepressants for preventing seasonal affective disorder in adults
Gartlehner, G., Nussbaumer, B., Gaynes, B. N., Forneris, C. A., Morgan, L. C., Kaminski-Hartenthaler, A., Greenblatt, A., Wipplinger, J., Lux, L. J., Sonis, J. H., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011268.pub2 · Cited by 30
Clinical trials and drug approvals continue to accelerate in China
Wang, M. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30406-0 · Cited by 18
Clinical trial in China: The status and challenge of data management and statistical analysis
Yao, C. (2018) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12295 · Cited by 13
Cited by
Kato, M., Hori, H., Inoue, T., Iga, J., Iwata, M., Inagaki, T., Shinohara, K., Imai, H., Murata, A., Mishima, K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0843-0 · Cited by 152
Self-citationFurukawa, T. A., Shinohara, K., Sahker, E., Karyotaki, E., Miguel, C., Ciharova, M., Bockting, C. L. H., Breedvelt, J. J. F., Tajika, A., Imai, H., et al. (2021) · World Psychiatry · doi:10.1002/wps.20906 · Cited by 126
Self-citationVitamin D Supplementation Ameliorates Severity of Major Depressive Disorder
AlGhamdi, S. A., Alsulami, N., Khoja, S., Alsufiani, H. M., Tayeb, H. O., & Tarazi, F. I. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01461-2 · Cited by 75
Martens, M., Filippini, N., Harmer, C. J., & Godlewska, B. R. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05915-7 · Cited by 47
Pain pathways and potential new targets for pain relief
Wang, M., & Thyagarajan, B. (2020) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2086 · Cited by 45
Metadata
- Authors
- Shinohara, K., Efthimiou, O., Ostinelli, E. G., Tomlinson, A., Geddes, J. R., Nierenberg, A. A., Ruhe, H. G., Furukawa, T. A., & Cipriani, A.
- Affiliations
- Kyoto University (JP)
- University of Bern (CH)
- University of Milan (IT)
- University of Oxford (GB)
- Oxford Health NHS Foundation Trust (GB)
- Massachusetts General Hospital (US)
- Department of Psychiatry, Radboud University, Nijmegen, the Netherlands
- Corresponding author
- Shinohara, Kiyomi
- ORCID
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2019-05-17
- Volume
- 9
- Issue
- 5
- Pages
- e027574
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC6530313
- OpenAlex
- W2944979889
- Cited by
- 27
- References
- 47
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 1
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HighWire Press Open Archive (acceptedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc)
- Radboud Repository (Radboud University) (submittedVersion, cc-by-nc-sa)
- BORIS (University Library Bern) (submittedVersion, cc-by-nc)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by-nc)
- Radboud Repository (Radboud University) (submittedVersion)
- Open Access CRIS of the University of Bern
- Funders
- National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre
- NIHR Research Professorship
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- major depressive disorder, antidepressants, long-term maintenance therapy, continuation treatment, relapse prevention, sustained response, treatment discontinuation, tolerability, acceptability, drug efficacy comparison, network meta-analysis
- MeSH terms
- Network Meta-Analysis as Topic, Systematic Reviews as Topic, Antidepressive Agents, Major Depressive Disorder, Humans, Research Design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
